A 15-year-old girl whose 'unbearable' itchy skin was initially mistaken for an allergy was eventually diagnosed with cancer .

Additionally, 66% of patients also reported reduced skin pain and itching. All patients were able to continue their initial EGFRi dosage for their cancer. There were no treatment-related adverse ...